Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-PD-L1 Monoclonal Antibody (Synonyms: Programmed cell death 1 ligand 1, B7 homolog 1)

Catalog No. TMAZ-0055 Copy Product Info
🥰Excellent
Anti-PD-L1 Monoclonal Antibody is a humanized rabbit antibody targeting PD-L1. Anti-PD-L1 Monoclonal Antibody can be used in ELISA,FCM,IF.

Anti-PD-L1 Monoclonal Antibody

Copy Product Info
🥰Excellent
Catalog No. TMAZ-0055
Synonyms Programmed cell death 1 ligand 1, B7 homolog 1

Anti-PD-L1 Monoclonal Antibody is a humanized rabbit antibody targeting PD-L1. Anti-PD-L1 Monoclonal Antibody can be used in ELISA,FCM,IF.

Anti-PD-L1 Monoclonal Antibody
Pack SizePriceUSA StockGlobal StockQuantity
25 μg$12012 days12 days
50 μg$14312 days12 days
100 μg$20112 days12 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-PD-L1 Monoclonal Antibody is a humanized rabbit antibody targeting PD-L1. Anti-PD-L1 Monoclonal Antibody can be used in ELISA,FCM,IF.
SynonymsProgrammed cell death 1 ligand 1, B7 homolog 1
Ig Type
Rabbit monoclonal IgG
Reactivity
Human
Verified Activity
Flow cytometry analysis of PD-L1 overexpressed 293F cells with TMAZ-0055BI, which was counjucated with SA-PE (red). The WT 293F control is black line.
Application
Recommended Dose
0.1-0.2 μg/10E6 cells for FCM; 1 ng/μl for ELISA
Antibody Type
Monoclonal
Host SpeciesRabbit
Subcellular LocalizationSecreted
ConstructionThis antibody was produced from a rabbit immunized with purified, recombinant human extracellular domain of PD-L1 protein.
PurificationProtein A Affinity Purified
AppearanceLiquid
Formulation0.22 μm filtered solution in PBS.
Purity> 95% as determined by SDS-PAGE.
Research BackgroundPlays a critical role in induction and maintenance of immune tolerance to self (PubMed: 11015443, PubMed: 28813410, PubMed: 28813417, PubMed: 31399419). As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response (PubMed: 11015443, PubMed: 28813410, PubMed: 28813417, PubMed: 36727298). Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (PubMed: 10581077). Can also act as a transcription coactivator: in response to hypoxia, translocates into the nucleus via its interaction with phosphorylated STAT3 and promotes transcription of GSDMC, leading to pyroptosis (PubMed: 32929201)|The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival (PubMed: 28813410, PubMed: 28813417). The interaction with PDCD1/PD-1 inhibits cytotoxic T lymphocytes (CTLs) effector function (By similarity). The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy (By similarity)
Related Conjugates and Formulations
Conjucates
Unconjugated
Others Formats
Biotin
Antibody Types Available
2
Antigen Details
Immunogen
PD-L1
Antigen Species
Human
Gene ID
Uniprot ID
Biology Area
Immunology Research
Chemical Properties
Molecular Weight150 kDa
Stability & Storage
Stability & StorageStore at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Anti-PD-L1 Monoclonal Antibody | purchase Anti-PD-L1 Monoclonal Antibody | Anti-PD-L1 Monoclonal Antibody cost | order Anti-PD-L1 Monoclonal Antibody | Anti-PD-L1 Monoclonal Antibody molecular weight